Skip to content

Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease

Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01897623
Acronym
CAD-AAA
Enrollment
Unknown
Registered
2013-07-12
Start date
2013-07-31
Completion date
2014-10-31
Last updated
2014-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm

Brief summary

The purpose of this study is to investigate the prevalence of abdominal aortic aneurysms (AAA) among male patients with coronary artery disease (CAD) verified in coronary angiography. Ethiology of AAA is known to be common with atherosclerotic arterial diseases (coronary artery disease, peripheral artery disease and carotid artery disease), so the hypothesis is that AAA should be more common among these CAD patients, thus making screening of these patients (for AAA) more cost-efficient. Study will be carried out as a multi-center prospective screening study. Data will be collected in North Karelia Central Hospital, Kuopio University Hospital and Tampere University Hospital. Data consists of 200 consecutive coronary angiography patients in each hospital, resulting in 600 patients in total. All male patients with diagnosed CAD will be recruited for the study and screened for AAA with ultrasound. Nevertheless, patients with previously known AAA will be excluded from the study.

Interventions

Sponsors

Kuopio University Hospital
CollaboratorOTHER
Tampere University Hospital
CollaboratorOTHER
North Karelia Central Hospital
Lead SponsorOTHER

Study design

Primary purpose
SCREENING

Eligibility

Sex/Gender
MALE

Inclusion criteria

* Male patients with coronary artery disease

Exclusion criteria

* Patient's denial to participate * Female Gender * Already diagnosed or treated abdominal aortic aneurysm

Design outcomes

Primary

MeasureTime frame
Maximum diameter (mm) of abdominal aorta (outer-to-outer wall) in ultrasoundupon screening

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026